Certican Tablets
Product Information *
Company:
Novartis Ireland LimitedStatus:
No Recent UpdateActive Ingredients :
*Additional information is available upon request
Legal Category:
Product subject to medical prescription which may not be renewed (A)
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 23 November 2020
File name
Certican REGPIL PF 19-0245 Nov 2020 Clean_1606122045.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 23 November 2020
File name
Certican tablet REGSmPC_PF 19-0245_clean Nov 2020_1606120813.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 12 May 2020
File name
March 2020 PF 19-0208 Certican tablet PIL CLEAN IE MT IPHA_1589272222.pdf
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 20 March 2020
File name
Certican tablets PIL Final Clean IPHA Oct 2019_1572620464.pdf
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 20 March 2020
File name
Certican tablet REGSPC PF 19-0208 March 2020 clean _1584706485.pdf
Reasons for updating
- Change to section 6.4 - Special precautions for storage
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 November 2019
File name
Certican tablets PIL Final Clean IPHA Oct 2019_1572620464.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 01 November 2019
File name
Certican tablet REGSmPC PF19-0114 October 2019 Clean_1572620384.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 22 March 2019
File name
Certican Tabs 2220789_IE_p3_LFT_X-4 RA Approved 13.03.2019_IPHA_1553252972.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 24 July 2018
File name
Certican tablet REGSmPC July 2018_Clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 19 May 2016
File name
PIL_16742_577.pdf
Reasons for updating
- New PIL for new product